Which is the best antiaggregant or anticoagulant therapy after TAVI? A propensity-matched analysis from the ITER registry. The management of DAPT after TAVI-Reference-Cited by-同舟云学术

Which is the best antiaggregant or anticoagulant therapy after TAVI? A propensity-matched analysis from the ITER registry. The management of DAPT after TAVI

Published:2017-12 Issue:12 Volume:13 Page:e1392-e1400
ISSN:1969-6213
Container-title:EuroIntervention
language:
Short-container-title:EuroIntervention

Author:

D'Ascenzo Fabrizio,Benedetto Umberto,Bianco Matteo,Conrotto Federico,Moretti Claudio,D'Onofrio Augusto,Agrifoglio Marco,Colombo Antonio,Ribichini Flavio,Tarantini Giuseppe,D'Amico Maurizio,Salizzoni Stefano,Rinaldi Mauro

Publisher

Europa Digital & Publishing

Subject

Cardiology and Cardiovascular Medicine

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcatheter Aortic Valve Replacement in Low Surgical Risk Patients: An Updated Metanalysis of Extended Follow-Up Randomized Controlled Trials;The American Journal of Cardiology;2024-08

2. Oral anticoagulants or antiplatelet drugs after heart valve reconstructive surgery: modern guidelines for the practitioners;Russian Journal of Cardiology;2024-02-02

3. Bleeding and thrombotic risk of different antiplatelet regimens posttranscatheter edge‐to‐edge mitral valve repair in patients with an indication for oral anticoagulation: Results from an all‐comers national registry;Catheterization and Cardiovascular Interventions;2023-12-11

4. Early 6 months usage of single anTiplAtelet OR anTicoAgulant followed by single antiplatelet after transcatheter aortic valve replacement: protocol for a multicentre, open-label, randomised controlled clinical trial;BMJ Open;2023-11

5. Optimal antiplatelet and antithrombotic regimen post‐transcatheter aortic valve replacement;European Journal of Clinical Investigation;2023-08-04